SHANGHAI YILE BIOTECHNOLOGY CO LTD has a total of 21 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MOUNTGATE GROUP LTD, IMMUNAS PHARMA INC and PACIFIC NORTHWEST RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Singapore | 2 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Cai Xiumei | 20 |
#2 | Dai Ruping | 20 |
#3 | Wang Huamao | 20 |
#4 | Zhou Xinfu | 11 |
#5 | Li Changqi | 11 |
#6 | Ruping Dai | 1 |
#7 | Xiumei Cai | 1 |
#8 | Changqi Li | 1 |
#9 | Xinfu Zhou | 1 |
#10 | Huamao Wang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019184920A1 | Use of probdnf regulator in b cell-related diseases | |
CA3074128A1 | Polypeptide and antibody bound to polypeptide | |
WO2016095839A1 | Application of binding molecule for specific binding of precursor for brain-derived neurotrophic factor |